ATP7A and colorectal carcinoma: Elesclomol suppressed the level of ATP7A in both CRC cell lines, whereas ATP7B was downregulated in SW480 cells but failed to be repressed in DLD‐1 cells (Fig. 3B and Fig. S2A,B).